Dems' Rejoicing Over the Supreme Court Ruling on Trump's Tariffs Got Wrecked...by CNN?
'Out of Nowhere' Canadians Are Now Poorer Than Alabamians. The Reactions Have Been...
Trump Shut Down CNN During Yesterday's Tariff Presser
Student ‘ICE Out’ Protests Go Viral Across US – Now Schools are Taking...
Here's Why the US Is Losing Farms at an Alarming Rate
This State Is Getting Closer to Eliminating Property Taxes
‘Privileged, White, and Well-Off’? Canada’s MAiD Program Just Got Even More Disturbing
How America Has Destroyed Its Democracy, Part Two: The Aristocracy of Merit
Three Congressional Missteps on Healthcare
Today’s Qualifications to Be President of the U.S.
It's True: Gavin Newsom's California Government Has Paid Protestors Over $100 Million
Three Iranian Nationals Indicted For Attempting to Sell Google Secrets to Home Country
Energy Security Is National Security: How America Maintains Its Military Edge
Ukraine's Bureaucrats Are Finishing What China Started
Rising Federal Debt: Why Strategic Planning Matters More Than Ever for High-Net-Worth Fami...
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’
AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos